TreatmentUpdate 72, Vol. 8, No. 8; October 1996
Doctors in the US recruited 323 HIV-infected women who had less
than 300 CD4+ cells for this study. One hundred and sixty-two
received fluconazole 200 mg/week and 161 received fake
fluconazole (placebo). Researchers monitored 50% of subjects
for 2 and a half years.
Thirteen subjects developed yeast infections; 6 in the
fluconazole group and 7 in the placebo group.
1. Vasquez JA, Steel-Moore L, Schuman P, et al .
Antifungal susceptibility among Candida species recovered from
HIV-positive women receiving fluconazole prophylaxis. Abstract